Search Results - "Deiman, Birgit A L M"

The Effect of Genotyping on the Number of Pharmacotherapeutic Gene-Drug Interventions in Chronic Kidney Disease Patients by Kerskes, Catharina H M, van den Eijnde, Carien J M E, Aarnoudse, Albert-Jan L H J, Grouls, René J E, Deiman, Birgit A L M, Deenen, Maarten J

“…Patients with chronic kidney disease (CKD) stage 3-5 are polypharmacy patients. Many of these drugs are metabolized by cytochrome P450 ( ) and Genetic…”
Get full text

Genetic association analysis and frequency of NUDT153 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort by Deenen, Maarten J., van Noordenburg, Anouk J., Bouwens-Bijsterveld, Joëlle, van Dijk, Maarten A., Stapelbroek, Janneke M., Derijks, Luc J. J., Gilissen, Lennard P. L., Deiman, Birgit A. L. M.

“…Thiopurine drugs are cornerstone treatment for patients with inflammatory bowel disease (IBD). The most common adverse drug reaction is thiopurine-induced…”
Get full text

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data by van der Lee, Maaike, Allard, William G, Vossen, Rolf H A M, Baak-Pablo, Renée F, Menafra, Roberta, Deiman, Birgit A L M, Deenen, Maarten J, Neven, Patrick, Johansson, Inger, Gastaldello, Stefano, Ingelman-Sundberg, Magnus, Guchelaar, Henk-Jan, Swen, Jesse J, Anvar, Seyed Yahya

“…Pharmacogenomics is a key component of personalized medicine that promises safer and more effective drug treatment by individualizing drug choice and dose…”
Get more information

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients by Hulshof, Emma C., de With, Mirjam, de Man, Femke M., Creemers, Geert-Jan, Deiman, Birgit A.L.M., Swen, Jesse J., Houterman, Saskia, Koolen, Stijn L.W., Bins, Sander, Thijs, Anna M.J., Laven, Marjan M.J., Hövels, Anke M., Luelmo, Saskia A.C., Houtsma, Danny, Shulman, Katerina, McLeod, Howard L., van Schaik, Ron H.N., Guchelaar, Henk-Jan, Mathijssen, Ron H.J., Gelderblom, Hans, Deenen, Maarten J.

“…To determine the safety, feasibility, pharmacokinetics, and cost of UGT1A1 genotype-guided dosing of irinotecan. In this prospective, multicentre,…”
Get full text

Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer by Visser, Esther, Genet, Sylvia A.A.M., de Kock, Remco P.P.A., van den Borne, Ben E.E.M., Youssef-El Soud, Maggy, Belderbos, Huub N.A., Stege, Gerben, de Saegher, Marleen E.A., van 't Westeinde, Susan C., Brunsveld, Luc, Broeren, Maarten A.C., van de Kerkhof, Daan, Deiman, Birgit A.L.M., Eduati, Federica, Scharnhorst, Volkher

“…•Protein TMs and ctDNA measured in liquid biopsy could support diagnosis and subtyping of lung cancer.•Liquid biopsy decision-support algorithms were trained…”
Get full text

Efficient Hydrolysis of RNA by a PNA - Diethylenetriamine Adduct by Verheijen, Jeroen C., Deiman, Birgit A. L. M., Yeheskiely, Esther, van der Marel, Gijs A., van Boom, Jacques H.

“…The introduction of a urea bond linking a protected diethylenetriamine (DETA) unit and the terminal amino group of a resin‐bound peptide nucleic acid (PNA)…”
Get full text

In vitro transcription by the turnip yellow mosaic virus RNA polymerase: a comparison with the alfalfa mosaic virus and brome mosaic virus replicases by Deiman, B.A.L.M, Verlaan, P.W.G, Pleij, C.W.A

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

High quality of SARS-CoV-2 molecular diagnostics in a diverse laboratory landscape through supported benchmark testing and External Quality Assessment by Sluimer, John, van den Akker, Willem M. R., Goderski, Gabriel, Swart, Arno, van der Veer, Bas, Cremer, Jeroen, Chung, Ngoc Hoa, Molenkamp, Richard, Voermans, Jolanda, Guldemeester, Judith, Eggink, Dirk, Presser, Lance D., Meijer, Adam

“…A two-step strategy combining assisted benchmark testing (entry controls) and External Quality Assessments (EQAs) with blinded simulated clinical specimens to…”
Get full text

Efficient Hydrolysis of RNA by a PNA - Diethylenetriamine Adduct by Verheijen, Jeroen C., Deiman, Birgit A. L. M., Yeheskiely, Esther, van der Marel, Gijs A., van Boom, Jacques H.

“…Die Einführung einer Harnstoffgruppe zur Verknüpfung einer geschützten Diethylentriamin(DETA)‐Einheit mit der terminalen Aminogruppe eines harzgebundenen…”
Get full text

Efficient Hydrolysis of RNA by a PNA – Diethylenetriamine Adduct by Verheijen, Jeroen C., Deiman, Birgit A. L. M., Yeheskiely, Esther, van der Marel, Gijs A., van Boom, Jacques H.

Get full text